Disease Markers
Volume 2014 (2014), Article ID 192836, 11 pages
http://dx.doi.org/10.1155/2014/192836
Renal Biopsy: Use of Biomarkers as a Tool for the Diagnosis of Focal Segmental Glomerulosclerosis
1Pathology Laboratory, Nephropathology Service, Federal University of Triângulo Mineiro, 38015-150 Uberaba, MG, Brazil
2Immunology Laboratory, Department of Biological Sciences, Federal University of Triângulo Mineiro, 58051-900 Uberaba, MG, Brazil
3Human Immunology Research and Education Group, Technical Health School of UFPB, Federal University of Paraíba, 38025-180 João Pessoa, PB, Brazil
Received 26 November 2013; Revised 15 January 2014; Accepted 15 January 2014; Published 25 February 2014
Academic Editor: Vincent Sapin
Copyright © 2014 Crislaine Aparecida da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- V. D. D'Agati, F. J. Kaskel, and R. J. Falk, “Focal segmental glomerulosclerosis,” The New England Journal of Medicine, vol. 365, no. 25, pp. 2398–2411, 2011. View at Publisher · View at Google Scholar · View at Scopus
- C. Schell and T. B. Huber, “New players in the pathogenesis of focal segmental glomerulosclerosis,” Nephrology Dialysis Transplantation, vol. 27, no. 9, pp. 3406–3412, 2012. View at Google Scholar
- M. Wehrmann, A. Bohle, H. Held, G. Schumm, H. Kendziorra, and H. Pressler, “Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes,” Clinical Nephrology, vol. 33, no. 3, pp. 115–122, 1990. View at Google Scholar · View at Scopus
- V. J. Savin, E. T. McCarthy, R. Sharma, D. Charba, and M. Sharma, “Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity,” Translational Research, vol. 151, no. 6, pp. 288–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
- P. F. Hoyer, B. Rodeck, M. Scherbring et al., “Development of liver size and perfusion after reduced-size liver transplantation in children,” Pediatric Transplantation, vol. 5, no. 3, pp. 192–197, 2001. View at Google Scholar · View at Scopus
- M. L. Artero, R. Sharma, V. J. Savin, and F. Vincenti, “Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis,” American Journal of Kidney Diseases, vol. 23, no. 4, pp. 574–581, 1994. View at Google Scholar · View at Scopus
- M. Haas, Y. Godfrin, R. Oberbauer et al., “Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis,” Nephrology Dialysis Transplantation, vol. 13, no. 8, pp. 2013–2016, 1998. View at Publisher · View at Google Scholar · View at Scopus
- M. J. Kemper, G. Wolf, and D. E. Müller-Wiefel, “Transmission of glomerular permeability factor from a mother to her child,” The New England Journal of Medicine, vol. 344, no. 5, pp. 386–387, 2001. View at Publisher · View at Google Scholar · View at Scopus
- J. Dantal, E. Bigot, W. Bogers et al., “Effect of plasma protein adsorption on protein excretion in kidney- transplant recipients with recurrent nephrotic syndrome,” The New England Journal of Medicine, vol. 330, no. 1, pp. 7–14, 1994. View at Publisher · View at Google Scholar · View at Scopus
- G. M. Ghiggeri, M. Artero, M. Carraro et al., “Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence,” Pediatric Transplantation, vol. 8, no. 4, pp. 339–343, 2004. View at Publisher · View at Google Scholar · View at Scopus
- R. Coppo, “Different targets for treating focal segmental glomerular sclerosis,” Contributions to Nephrology, vol. 181, pp. 84–90, 2013. View at Google Scholar
- W. W. Bakker, C. M. L. van Dael, L. J. W. M. Pierik et al., “Altered activity of plasma hemopexin in patients with minimal change disease in relapse,” Pediatric Nephrology, vol. 20, no. 10, pp. 1410–1415, 2005. View at Publisher · View at Google Scholar · View at Scopus
- E. T. McCarthy, M. Sharma, and V. J. Savin, “Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 11, pp. 2115–2121, 2010. View at Publisher · View at Google Scholar · View at Scopus
- A. Koch, S. Voigt, C. Kruschinski et al., “Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients,” Critical Care, vol. 15, no. 1, article R63, 2011. View at Publisher · View at Google Scholar · View at Scopus
- M. Hillman and M. Olsson-Landin, “Soluble urokinase-plasminogen activator receptor (suPAR) and natural phosphorylcholine IgM antibodies in patients at clinical onset of diabetes mellitus,” Journal of Diabetes Mellitus, vol. 1, no. 4, pp. 96–103, 2011. View at Google Scholar
- C. Wei, C. C. Möller, M. M. Altintas et al., “Modification of kidney barrier function by the urokinase receptor,” Nature Medicine, vol. 14, no. 1, pp. 55–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
- R. Krishnan, M. Kremen, J. H. Hu et al., “Level of macrophage uPA expression is an important determinant of atherosclerotic lesion growth in apoe-/- mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1737–1744, 2009. View at Publisher · View at Google Scholar · View at Scopus
- A. Mondino and F. Blasi, “uPA and uPAR in fibrinolysis, immunity and pathology,” Trends in Immunology, vol. 25, no. 8, pp. 450–455, 2004. View at Publisher · View at Google Scholar · View at Scopus
- Y. Wei, M. Lukashev, D. I. Simon et al., “Regulation of integrin function by the urokinase receptor,” Science, vol. 273, no. 5281, pp. 1551–1555, 1996. View at Google Scholar · View at Scopus
- Y. Wei, R.-P. Czekay, L. Robillard et al., “Regulation of α5β1 integrin conformation and function by urokinase receptor binding,” Journal of Cell Biology, vol. 168, no. 3, pp. 501–511, 2005. View at Publisher · View at Google Scholar · View at Scopus
- F. Blasi and P. Carmeliet, “uPAR: a versatile signalling orchestrator,” Nature Reviews Molecular Cell Biology, vol. 3, no. 12, pp. 932–943, 2002. View at Publisher · View at Google Scholar · View at Scopus
- H. W. Smith and C. J. Marshall, “Regulation of cell signalling by uPAR,” Nature Reviews Molecular Cell Biology, vol. 11, no. 1, pp. 23–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
- J. Huang, G. Liu, Y. M. Zhang et al., “Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis,” Kidney International, vol. 84, no. 2, pp. 366–372, 2013. View at Google Scholar
- C. Wei, H. Trachtman, J. Li et al., “Circulating suPAR in two cohorts of primary FSGS,” Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2051–2059, 2012. View at Google Scholar
- C. R. Franco Palacios, J. C. Lieske, H. M. Wadei et al., “Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates,” Transplantation, vol. 96, no. 4, pp. 394–399, 2013. View at Google Scholar
- M. E. Bock, H. E. Price, L. Gallon, and C. B. Langman, “Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 8, pp. 1304–1311, 2013. View at Google Scholar
- C. Wei, S. El Hindi, J. Li et al., “Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis,” Nature Medicine, vol. 17, no. 8, pp. 952–960, 2011. View at Publisher · View at Google Scholar · View at Scopus
- B. Bauvois, N. Mothu, J. Nguyen, T. Nguyen-Khoa, L.-H. Nöel, and P. Jungers, “Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-β1 in patients with distinct types of primary glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 1115–1122, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. Strehlau, A. D. Schachter, M. Pavlakis, A. Singh, A. Tejani, and T. B. Strom, “Activated intrarenal transcription of CTL-effectors and TGF-β1 in children with focal segmental glomerulosclerosis,” Kidney International, vol. 61, no. 1, pp. 90–95, 2002. View at Publisher · View at Google Scholar · View at Scopus
- J. H. Kim, B. K. Kim, K. C. Moon, H. K. Hong, and H. S. Lee, “Activation of the TGF-β/Smad signaling pathway in focal segmental glomerulosclerosis,” Kidney International, vol. 64, no. 5, pp. 1715–1721, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. Wang, J. H. Kim, K. C. Moon, H. K. Hong, and H. S. Lee, “Cell-Cycle Mechanisms Involved in Podocyte Proliferation in Cellular Lesion of Focal Segmental Glomerulosclerosis,” American Journal of Kidney Diseases, vol. 43, no. 1, pp. 19–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
- M. Schiffer, M. Bitzer, I. S. D. Roberts et al., “Apoptosis in podocytes induced by TGF-β and Smad7,” Journal of Clinical Investigation, vol. 108, no. 6, pp. 807–816, 2001. View at Publisher · View at Google Scholar · View at Scopus
- M. V. Antunes, C. Lazzaretti, G. D. Gamaro, and R. Linden, “Estudo pré-analítico e de validação para determinação de malondialdeído em plasma humano por cromatografia líquida de alta eficiência, após derivatização com 2, 4-dinitrofenilhidrazina,” Revista Brasileira De Ciências Farmacêuticas, vol. 44, pp. 279–287, 2008. View at Google Scholar
- R. Agarwal, “Chronic kidney disease is associated with oxidative stress independent of hypertension,” Clinical Nephrology, vol. 61, no. 6, pp. 377–383, 2004. View at Google Scholar · View at Scopus
- A. Ece, S. Kelekçi, H. Kocamaz et al., “Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura,” Clinical rheumatology, vol. 27, no. 2, pp. 163–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
- H.-T. Kuo, M.-C. Kuo, Y.-W. Chiu, J.-M. Chang, J.-Y. Guh, and H.-C. Chen, “Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis,” European Journal of Clinical Investigation, vol. 35, no. 4, pp. 245–250, 2005. View at Publisher · View at Google Scholar · View at Scopus
- S. T. Nezhad, B. Momeni, and M. Basiratnia, “Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease,” Saudi Journal of Kidney Diseases and Transplantation, vol. 21, no. 5, pp. 886–891, 2010. View at Google Scholar · View at Scopus
- C. J. Binder, H. Weiher, M. Exner, and D. Kerjaschki, “Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria. A model of steroid-resistant nephrosis sensitive to radical scavenger therapy,” American Journal of Pathology, vol. 154, no. 4, pp. 1067–1075, 1999. View at Google Scholar · View at Scopus
- H. M. Regele, E. Fillipovic, B. Langer et al., “Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis,” Journal of the American Society of Nephrology, vol. 11, no. 3, pp. 403–412, 2000. View at Google Scholar · View at Scopus
- G. Giannico, H. Yang, E. G. Neilson, and A. B. Fogo, “Dystroglycan in the diagnosis of FSGS,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 11, pp. 1747–1753, 2009. View at Publisher · View at Google Scholar · View at Scopus
- K. Kojima and D. Kerjaschki, “Is podocyte shape controlled by the dystroglycan complex?” Nephrology Dialysis Transplantation, vol. 17, supplement 9, pp. 23–24, 2002. View at Google Scholar · View at Scopus
- J. Reiser, K. R. Polu, C. C. Möller et al., “TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function,” Nature Genetics, vol. 37, no. 7, pp. 739–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
- M. P. Winn, P. J. Conlon, K. L. Lynn et al., “Medicine: a mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis,” Science, vol. 308, no. 5729, pp. 1801–1804, 2005. View at Publisher · View at Google Scholar · View at Scopus
- X. Cai, Z. Xia, C. Zhang et al., “Serum microRNAs levels in primary focal segmental glomerulosclerosis,” Pediatric Nephrology, vol. 28, no. 9, pp. 1797–1801, 2013. View at Google Scholar
- Z. Tian, A. S. Greene, J. L. Pietrusz, I. R. Matus, and M. Liang, “MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis,” Genome Research, vol. 18, no. 3, pp. 404–411, 2008. View at Publisher · View at Google Scholar · View at Scopus
- H.-R. Chang, W.-H. Kuo, Y.-S. Hsieh et al., “Circulating matrix metalloproteinase-2 is associated with cystatin C level, posttransplant duration, and diabetes mellitus in kidney transplant recipients,” Translational Research, vol. 151, no. 4, pp. 217–223, 2008. View at Publisher · View at Google Scholar · View at Scopus
- K. Uchio-Yamada, N. Manabe, Y. Goto et al., “Decreased expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in the kidneys of hereditary nephrotic (ICGN) mice,” Journal of Veterinary Medical Science, vol. 67, no. 1, pp. 35–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
- S. Liu, Y. Li, H. Zhao et al., “Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats,” Molecular and Cellular Biochemistry, vol. 284, no. 1-2, pp. 9–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
- J. Mishra, C. Dent, R. Tarabishi et al., “Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery,” The Lancet, vol. 365, no. 9466, pp. 1231–1238, 2005. View at Publisher · View at Google Scholar · View at Scopus
- K. Mori, H. T. Lee, D. Rapoport et al., “Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 610–621, 2005. View at Publisher · View at Google Scholar · View at Scopus
- M. Bennett, C. L. Dent, Q. Ma et al., “Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 3, pp. 665–673, 2008. View at Publisher · View at Google Scholar · View at Scopus
- D. M. Youssef and A. A. El-Shal, “Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis,” Iranian Journal of Kidney Diseases, vol. 6, no. 5, pp. 355–360, 2012. View at Google Scholar
- J. Reiser, C. Wei, and J. Tumlin, “Soluble urokinase receptor and focal segmental glomerulosclerosis,” Current Opinion in Nephrology and Hypertension, vol. 21, no. 4, pp. 428–432, 2012. View at Google Scholar
- L. H. Beck Jr., R. G. B. Bonegio, G. Lambeau et al., “M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy,” The New England Journal of Medicine, vol. 361, no. 1, pp. 11–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
- S. Sever, H. Trachtman, C. Wei, and J. Reiser, “Is there clinical value in measuring suPAR levels in FSGS?” Clinical Journal of the American Society of Nephrology, vol. 8, no. 8, pp. 1273–1275, 2013. View at Google Scholar
- G. C. A. Elson, E. Lelièvre, C. Guillet et al., “CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex,” Nature Neuroscience, vol. 3, no. 9, pp. 867–872, 2000. View at Publisher · View at Google Scholar · View at Scopus
- G. Senaldi, B. C. Varnum, C. S. Ulla Sarmiento et al., “Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11458–11463, 1999. View at Publisher · View at Google Scholar · View at Scopus
- G. C. A. Elson, P. Graber, C. Losberger et al., “Cytokine-like factor-1, a novel soluble protein, shares homology with members of the cytokine type I receptor family,” Journal of Immunology, vol. 161, no. 3, pp. 1371–1379, 1998. View at Google Scholar · View at Scopus
- Y. Shi, W. Wang, P. A. Yourey et al., “Computational EST database analysis identifies a novel member of the neuropoietic cytokine family,” Biochemical and Biophysical Research Communications, vol. 262, no. 1, pp. 132–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
- D. Derouet, F. Rousseau, F. Alfonsi et al., “Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4827–4832, 2004. View at Publisher · View at Google Scholar · View at Scopus
- J. F. Bazan, “Neuropoietic cytokines in the hematopoietic fold,” Neuron, vol. 7, no. 2, pp. 197–208, 1991. View at Publisher · View at Google Scholar · View at Scopus
- F. Rousseau, J.-F. Gauchat, J. G. McLeod et al., “Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 26, pp. 10068–10073, 2006. View at Publisher · View at Google Scholar · View at Scopus
- L. Stefanovic and B. Stefanovic, “Role of cytokine receptor-like factor 1 in hepatic stellate cells and fibrosis,” World Journal of Hepatology, vol. 4, no. 12, pp. 356–364, 2012. View at Google Scholar
- X.-L. Xie, M. Wei, A. Kakehashi, S. Yamano, M. Tajiri, and H. Wanibuchi, “2-amino-3-methylimidazo[4,5-f]quinoline (iq) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways,” Toxicological Sciences, vol. 125, no. 2, pp. 392–400, 2012. View at Publisher · View at Google Scholar · View at Scopus
- L. E. Becker, N. Koleganova, G. Piecha et al., “Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice,” American Journal of Physiology—Renal Physiology, vol. 300, no. 3, pp. F772–F782, 2011. View at Publisher · View at Google Scholar · View at Scopus
- S. Nakamaki, H. Satoh, A. Kudoh, Y. Hayashi, H. Hirai, and T. Watanabe, “Adiponectin reduces proteinuria in streptozotocin-induced diabetic wistar rats,” Experimental Biology and Medicine, vol. 236, no. 5, pp. 614–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
- S. Marwitz, M. Abdullah, C. Vock et al., “HOPE-BAL: improved molecular diagnostics by application of a novel technique for fixation and paraffin embedding,” Journal of Histochemistry and Cytochemistry, vol. 59, no. 6, pp. 601–614, 2011. View at Publisher · View at Google Scholar · View at Scopus
- J.-X. Yin, J.-L. Tu, H.-J. Lin et al., “Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model,” PLoS ONE, vol. 5, no. 8, Article ID e12400, 2010. View at Publisher · View at Google Scholar · View at Scopus
- V. J. Vieira, A. J. D'Acampora, A. B. W. Marcos et al., “Vascular endothelial growth factor overexpression positively modulates the characteristics of periprosthetic tissue of polyurethane-coated silicone breast implant in rats,” Plastic and Reconstructive Surgery, vol. 126, no. 6, pp. 1899–1910, 2010. View at Publisher · View at Google Scholar · View at Scopus
- H.-K. Yap, W. Cheung, B. Murugasu, S.-K. Sim, C.-C. Seah, and S. C. Jordan, “Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse,” Journal of the American Society of Nephrology, vol. 10, no. 3, pp. 529–537, 1999. View at Google Scholar · View at Scopus
- L. le Berre, C. Hervé, F. Buzelen, C. Usal, J.-P. Soulillou, and J. Dantal, “Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats,” Kidney International, vol. 68, no. 5, pp. 2079–2090, 2005. View at Publisher · View at Google Scholar · View at Scopus
- K.-W. Lai, C.-L. Wei, L.-K. Tan et al., “Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats,” Journal of the American Society of Nephrology, vol. 18, no. 5, pp. 1476–1485, 2007. View at Publisher · View at Google Scholar · View at Scopus
- R. L. Pereira, V. O. Reis, P. Semedo et al., “Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis,” PLoS ONE, vol. 7, no. 3, Article ID e32454, 2012. View at Publisher · View at Google Scholar · View at Scopus
- B. M. Brenner, T. W. Meyer, and T. H. Hostetter, “Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease,” The New England Journal of Medicine, vol. 307, no. 11, pp. 652–659, 1982. View at Google Scholar · View at Scopus
- S. Anderson, T. W. Meyer, H. G. Rennke, and B. M. Brenner, “Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass,” Journal of Clinical Investigation, vol. 76, no. 2, pp. 612–619, 1985. View at Google Scholar · View at Scopus
- J. W. U. Fries, D. J. Sandstrom, T. W. Meyer, and H. G. Rennke, “Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat,” Laboratory Investigation, vol. 60, no. 2, pp. 205–218, 1989. View at Google Scholar · View at Scopus
- A. Remuzzi, S. Puntorieri, C. Battaglia, T. Bertani, and G. Remuzzi, “Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat,” Journal of Clinical Investigation, vol. 85, no. 2, pp. 541–549, 1990. View at Google Scholar · View at Scopus
- H. S. Lee, “Pathogenic role of TGF-β in the progression of podocyte diseases,” Histology and Histopathology, vol. 26, no. 1, pp. 107–116, 2011. View at Google Scholar · View at Scopus
- K. Miyazono, P. Ten Dijke, and C.-H. Heldin, “TGF-β signaling by Smad proteins,” Advances in Immunology, vol. 75, pp. 115–157, 2000. View at Google Scholar · View at Scopus
- J. Massagué and D. Wotton, “Transcriptional control by the TGF-β/Smad signaling system,” The EMBO Journal, vol. 19, no. 8, pp. 1745–1754, 2000. View at Google Scholar · View at Scopus
- Y. S. Kang, Y. Li, C. Dai, L. P. Kiss, C. Wu, and Y. Liu, “Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria,” Kidney International, vol. 78, no. 4, pp. 363–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
- X. Kong, Y. Zhang, H. B. Wu, F. X. Li, D. Y. Zhang, and Q. Su, “Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 856085, 9 pages, 2012. View at Publisher · View at Google Scholar
- B.-Y. Chen, D. P.-C. Lin, C.-Y. Wu et al., “Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation,” Molecular Vision, vol. 17, pp. 854–863, 2011. View at Google Scholar · View at Scopus
- G. M. Denicola, F. A. Karreth, T. J. Humpton et al., “Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis,” Nature, vol. 475, no. 7354, pp. 106–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
- F. Neria, M. A. Castilla, R. F. Sanchez et al., “Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity,” Kidney International, vol. 75, no. 2, pp. 227–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
- L.-W. Fan, H. J. Mitchell, L.-T. Tien, P. G. Rhodes, and Z. Cai, “Interleukin-1β-induced brain injury in the neonatal rat can be ameliorated by α-phenyl-n-tert-butyl-nitrone,” Experimental Neurology, vol. 220, no. 1, pp. 143–153, 2009. View at Publisher · View at Google Scholar · View at Scopus
- L.-W. Fan, H. J. Mitchell, P. G. Rhodes, and Z. Cai, “α-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain,” Neuroscience, vol. 151, no. 3, pp. 737–744, 2008. View at Publisher · View at Google Scholar · View at Scopus
- M. Mancuso, G. Davidzon, R. M. Kurlan et al., “Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights,” Journal of Neuropathology and Experimental Neurology, vol. 64, no. 4, pp. 280–294, 2005. View at Google Scholar · View at Scopus
- B. Chance, H. Sies, and A. Boveris, “Hydroperoxide metabolism in mammalian organs,” Physiological Reviews, vol. 59, no. 3, pp. 527–605, 1979. View at Google Scholar · View at Scopus
- J.-M. Chang, M.-C. Kuo, H.-T. Kuo, Y.-W. Chiu, and H.-C. Chen, “Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy,” Journal of Laboratory and Clinical Medicine, vol. 146, no. 4, pp. 210–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
- A. L. Ferreira and L. S. Matsubara, “Free radicals: concepts, associated diseases, defense system and oxidative stress,” Revista da Associação Médica Brasileira, vol. 43, no. 1, pp. 61–68, 1997. View at Google Scholar · View at Scopus
- M. Shimojima, U. Ströher, H. Ebihara, H. Feldmann, and Y. Kawaoka, “Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry,” Journal of Virology, vol. 86, no. 4, pp. 2067–2078, 2012. View at Publisher · View at Google Scholar · View at Scopus
- D. Takawira, G. R. S. Budinger, S. B. Hopkinson, and J. C. R. Jones, “A dystroglycan/plectin scaffold mediates mechanical pathway bifurcation in lung epithelial cells,” Journal of Biological Chemistry, vol. 286, no. 8, pp. 6301–6310, 2011. View at Publisher · View at Google Scholar · View at Scopus
- Z. Zhang, P. Zhang, and H. Hu, “Large expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding,” PLoS ONE, vol. 6, no. 4, Article ID e19080, 2011. View at Publisher · View at Google Scholar · View at Scopus
- E. Zanoteli, D. V. de Vlekkert, E. J. Bonten et al., “Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue,” Biochimica et Biophysica Acta, vol. 1802, no. 7-8, pp. 659–672, 2010. View at Publisher · View at Google Scholar · View at Scopus
- L. Khouzami, M.-C. Bourin, C. Christov et al., “Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource,” American Journal of Pathology, vol. 177, no. 3, pp. 1356–1364, 2010. View at Publisher · View at Google Scholar · View at Scopus
- K. Schlie, A. Maisa, F. Freiberg, A. Groseth, T. Strecker, and W. Garten, “Viral protein determinants of Lassa virus entry and release from polarized epithelial cells,” Journal of Virology, vol. 84, no. 7, pp. 3178–3188, 2010. View at Publisher · View at Google Scholar · View at Scopus
- V. T. Ribeiro-Resende, M. L. Ribeiro-Guimarães, R. M. Rodrigues Lemes et al., “Involvement of 9-O-acetyl GD3 ganglioside in Mycobacterium leprae infection of schwann cells,” Journal of Biological Chemistry, vol. 285, no. 44, pp. 34086–34096, 2010. View at Publisher · View at Google Scholar · View at Scopus
- S. H. Gee, F. Montanaro, M. H. Lindenbaum, and S. Carbonetto, “Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor,” Cell, vol. 77, no. 5, pp. 675–686, 1994. View at Publisher · View at Google Scholar · View at Scopus
- R. Timpl, D. Tisi, J. F. Talts, Z. Andac, T. Sasaki, and E. Hohenester, “Structure and function of laminin LG modules,” Matrix Biology, vol. 19, no. 4, pp. 309–317, 2000. View at Publisher · View at Google Scholar · View at Scopus
- C. J. Ilse Raats, J. van den Born, M. A. H. Bakker et al., “Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies,” American Journal of Pathology, vol. 156, no. 5, pp. 1749–1765, 2000. View at Google Scholar · View at Scopus
- J. L. Ilsley, M. Sudol, and S. J. Winder, “The WW domain: linking cell signalling to the membrane cytoskeleton,” Cellular Signalling, vol. 14, no. 3, pp. 183–189, 2002. View at Publisher · View at Google Scholar · View at Scopus
- K. Itsuki, Y. Imai, Y. Okamura, K. Abe, R. Inoue, and M. X. Mori, “Voltage-sensing phosphatase reveals temporal regulation of TRPC3/C6/C7 channels by membrane phosphoinositides,” Channels, vol. 6, no. 3, pp. 206–209, 2012. View at Google Scholar
- M. Trebak, L. Lemonnier, J. T. Smyth, G. Vazquez, and J. W. Putney Jr., “Phospholipase C-coupled receptors and activation of TRPC channels,” Handbook of Experimental Pharmacology, no. 179, pp. 593–614, 2007. View at Google Scholar · View at Scopus
- C. Montell, “The TRP superfamily of cation channels,” Science's STKE, vol. 2005, no. 272, p. re3, 2005. View at Google Scholar · View at Scopus
- N. Mukerji, T. V. Damodaran, and M. P. Winn, “TRPC6 and FSGS: the latest TRP channelopathy,” Biochimica et Biophysica Acta, vol. 1772, no. 8, pp. 859–868, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. Goel, W. Sinkins, A. Keightley, M. Kinter, and W. P. Schilling, “Proteomic analysis of TRPC5- and TRPC6-binding partners reveals interaction with the plasmalemmal Na+/K+-ATPase,” Pflugers Archiv European Journal of Physiology, vol. 451, no. 1, pp. 87–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
- W. Kriz, M. Elger, P. Mundel, and K. V. Lemley, “Structure-stabilizing forces in the glomerular tuft,” Journal of the American Society of Nephrology, vol. 5, no. 10, pp. 1731–1739, 1995. View at Google Scholar · View at Scopus
- A. Dietrich, M. Mederos y Schnitzler, H. Kalwa, U. Storch, and T. Gudermann, “Functional characterization and physiological relevance of the TRPC3/6/7 subfamily of cation channels,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 371, no. 4, pp. 257–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
- N. Weissmann, A. Dietrich, B. Fuchs et al., “Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 50, pp. 19093–19098, 2006. View at Publisher · View at Google Scholar · View at Scopus
- M. A. Cortez and G. A. Calin, “MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases,” Expert Opinion on Biological Therapy, vol. 9, no. 6, pp. 703–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
- P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
- M. Hanke, K. Hoefig, H. Merz et al., “A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer,” Urologic Oncology, vol. 28, no. 6, pp. 655–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
- Y. Liang, D. Ridzon, L. Wong, and C. Chen, “Characterization of microRNA expression profiles in normal human tissues,” BMC Genomics, vol. 8, article 166, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. Keeling and G. A. Herrera, “Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis,” Microscopy Research and Technique, vol. 71, no. 5, pp. 371–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
- J. M. Catania, G. Chen, and A. R. Parrish, “Role of matrix metalloproteinases in renal pathophysiologies,” American Journal of Physiology—Renal Physiology, vol. 292, no. 3, pp. F905–F911, 2007. View at Publisher · View at Google Scholar · View at Scopus
- C. Tallant, A. Marrero, and F. X. Gomis-Rüth, “Matrix metalloproteinases: fold and function of their catalytic domains,” Biochimica et Biophysica Acta, vol. 1803, no. 1, pp. 20–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
- K. M. Thrailkill, R. Clay Bunn, and J. L. Fowlkes, “Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy,” Endocrine, vol. 35, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
- W.-H. Liu, N.-N. Tang, and Q.-D. Zhang, “Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?” Chinese Medical Journal, vol. 122, no. 2, pp. 199–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
- A. Korzeniecka-Kozerska, A. Wasilewska, E. Tenderenda, A. Sulik, and K. Cybulski, “Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children,” Disease Markers, vol. 34, no. 5, pp. 357–362, 2013. View at Google Scholar
- J. Bolbrinker, S. Markovic, M. Wehland, W. B. W. H. Melenhorst, H. van Goor, and R. Kreutz, “Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 1, pp. 8–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
- M. Urushihara, S. Kagami, T. Kuhara, T. Tamaki, and Y. Kuroda, “Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 17, no. 7, pp. 1189–1196, 2002. View at Google Scholar · View at Scopus
- K. A. Czech, M. Bennett, and P. Devarajan, “Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis,” Pediatric Nephrology, vol. 26, no. 12, pp. 2179–2184, 2011. View at Publisher · View at Google Scholar · View at Scopus
- D. R. Flower, “The lipocalin protein family: structure and function,” Biochemical Journal, vol. 318, part 1, pp. 1–14, 1996. View at Google Scholar · View at Scopus
- T. McCormick and R. Venn, “Recently published papers: tracheostomy: why rather than when? Obesity: does it matter? And stroke: diagnosis, thrombosis and prognosis,” Critical Care, vol. 11, no. 2, article 127, 2007. View at Publisher · View at Google Scholar · View at Scopus
- K. Tryggvason and E. Pettersson, “Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure,” Journal of Internal Medicine, vol. 254, no. 3, pp. 216–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
- B. Hultberg and U. Ravnskov, “The excretion of N-acetyl-β-glucosaminidase in glomerulonephritis,” Clinical Nephrology, vol. 15, no. 1, pp. 33–38, 1981. View at Google Scholar · View at Scopus